Evofem Biosciences Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Saundra Pelletier
Chief executive officer
US$3.2m
Total compensation
| CEO salary percentage | 25.4% |
| CEO tenure | 5yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.4yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$283m |
| Mar 31 2022 | n/a | n/a | -US$192m |
| Dec 31 2021 | US$3m | US$812k | -US$206m |
| Sep 30 2021 | n/a | n/a | -US$194m |
| Jun 30 2021 | n/a | n/a | -US$150m |
| Mar 31 2021 | n/a | n/a | -US$169m |
| Dec 31 2020 | US$4m | US$781k | -US$142m |
| Sep 30 2020 | n/a | n/a | -US$114m |
| Jun 30 2020 | n/a | n/a | -US$98m |
| Mar 31 2020 | n/a | n/a | -US$81m |
| Dec 31 2019 | US$3m | US$847k | -US$80m |
| Sep 30 2019 | n/a | n/a | -US$82m |
| Jun 30 2019 | n/a | n/a | -US$87m |
| Mar 31 2019 | n/a | n/a | -US$75m |
| Dec 31 2018 | US$8m | US$738k | -US$126m |
| Sep 30 2018 | n/a | n/a | -US$131m |
| Jun 30 2018 | n/a | n/a | -US$188m |
| Mar 31 2018 | n/a | n/a | -US$172m |
| Dec 31 2017 | US$2m | US$731k | -US$109m |
| Sep 30 2017 | n/a | n/a | -US$103m |
| Dec 31 2016 | US$6m | US$589k | -US$69m |
Compensation vs Market: Saundra's total compensation ($USD3.19M) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Saundra's compensation has been consistent with company performance over the past year.
CEO
Saundra Pelletier (52 yo)
5yrs
Tenure
US$3,193,925
Compensation
Ms. Saundra Pelletier has been Chief Executive Officer and President of Evofem Biosciences, Inc. since January 17, 2018. Ms. Pelletier has been an Executive Director of Evofem Biosciences, Inc. since Janua...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim Chair | 5yrs | US$3.19m | 0.20% $ 14.4k | |
| CFO & Secretary | 5yrs | US$1.26m | 0.045% $ 3.3k | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Vice President of Sales | 1.8yrs | no data | no data | |
| Head of Business Development | less than a year | no data | no data | |
| Chief Commercial Officer | no data | no data | 0.014% $ 1.0k |
3.4yrs
Average Tenure
52yo
Average Age
Experienced Management: 1AQ's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim Chair | 5yrs | US$3.19m | 0.20% $ 14.4k | |
| Independent Director | 2.9yrs | US$140.35k | 0.00056% $ 41.2 | |
| Independent Director | 5yrs | US$159.48k | 0.0011% $ 78.1 | |
| Independent Director | 5yrs | US$150.73k | 0% $ 0 | |
| Independent Director | 5yrs | US$158.23k | 0% $ 0 | |
| Independent Director | 5yrs | US$163.23k | no data | |
| Director | less than a year | no data | no data |
5.0yrs
Average Tenure
60.5yo
Average Age
Experienced Board: 1AQ's board of directors are considered experienced (5 years average tenure).